APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral Contrast Agent

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Oral Contrast Agent Industry Growth and Trends Forecast to 2032

19 December 2025101 pages

Choose your research edition.

Industry ResearchOral Contrast Agent Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Contrast Agent Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Oral Contrast Agent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Contrast Agent Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Contrast Agent Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Oral Contrast Agent market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Oral Contrast Agent is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Oral Contrast Agent is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oral Contrast Agent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Oral Contrast Agent include Daiichi Sankyo (Japan), Bayer HealthCare (Germany), Unijules Life Sciences (India), Taejoon Pharm (South Korea), Spago Nanomedicine (Sweden), Magnus Health (India), Lantheus (US), Jodas (India) and J.B. Chemicals and Pharmaceuticals (India), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Oral Contrast Agent market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Oral Contrast Agent market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Oral Contrast Agent market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Oral Contrast Agent.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Oral Contrast Agent market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Oral Contrast Agent Market by Company

Daiichi Sankyo (Japan)

Bayer HealthCare (Germany)

Unijules Life Sciences (India)

Taejoon Pharm (South Korea)

Spago Nanomedicine (Sweden)

Magnus Health (India)

Lantheus (US)

Jodas (India)

J.B. Chemicals and Pharmaceuticals (India)

Guerbet (France)

GE Healthcare (US)

Bracco Imaging (Italy)

Oral Contrast Agent Segment by Type

Microbubble Contrast Media

Gadolinium-based Contrast Media

Iodinated Contrast Media

Barium-based Contrast Media

Oral Contrast Agent Segment by Application

Cardiovascular Disorders

Gastrointestinal Disorders

Nephrological Disorders

Neurological Disorders

Musculoskeletal Disorders

Cancer

Oral Contrast Agent Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Contrast Agent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Contrast Agent and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Contrast Agent.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oral Contrast Agent manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Oral Contrast Agent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Microbubble Contrast Media Table 2. Major Company of Gadolinium-based Contrast Media Table 3. Major Company of Iodinated Contrast Media Table 4. Major Company of Barium-based Contrast Media Table 5. Global Oral Contrast Agent Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Oral Contrast Agent Sales by Type (2021-2026) & (K Units) Table 7. Global Oral Contrast Agent Sales Market Share in Volume by Type (2021-2026) Table 8. Global Oral Contrast Agent Sales by Type (2021-2026) & (US$ Million) Table 9. Global Oral Contrast Agent Sales Market Share in Value by Type (2021-2026) Table 10. Global Oral Contrast Agent Price by Type (2021-2026) & (US$/Unit) Table 11. Global Oral Contrast Agent Sales by Type (2027-2032) & (K Units) Table 12. Global Oral Contrast Agent Sales Market Share in Volume by Type (2027-2032) Table 13. Global Oral Contrast Agent Sales by Type (2027-2032) & (US$ Million) Table 14. Global Oral Contrast Agent Sales Market Share in Value by Type (2027-2032) Table 15. Global Oral Contrast Agent Price by Type (2027-2032) & (US$/Unit) Table 16. North America Oral Contrast Agent Sales by Type (2021-2026) & (K Units) Table 17. North America Oral Contrast Agent Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Oral Contrast Agent Sales by Type (2021-2026) & (K Units) Table 19. Europe Oral Contrast Agent Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Oral Contrast Agent Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Oral Contrast Agent Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Oral Contrast Agent Sales by Type (2021-2026) & (K Units) Table 23. Latin America Oral Contrast Agent Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Oral Contrast Agent Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Oral Contrast Agent Sales by Type (2021-2026) & (US$ Million) Table 26. Oral Contrast Agent Industry Trends Table 27. Oral Contrast Agent Industry Drivers Table 28. Oral Contrast Agent Industry Opportunities and Challenges Table 29. Oral Contrast Agent Industry Restraints Table 30. Global Oral Contrast Agent Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Oral Contrast Agent Revenue Market Share by Company (2021-2026) Table 32. Global Oral Contrast Agent Sales by Company (2021-2026) & (K Units) Table 33. Global Oral Contrast Agent Sales Share by Company (2021-2026) Table 34. Global Oral Contrast Agent Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Oral Contrast Agent Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Oral Contrast Agent Major Company Production Sites and Headquarters Table 37. Global Oral Contrast Agent Company, Product Type & Application Table 38. Global Oral Contrast Agent Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Oral Contrast Agent by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Oral Contrast Agent Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Oral Contrast Agent Sales by Region (2021-2026) & (K Units) Table 43. Global Oral Contrast Agent Sales Market Share in Volume by Region (2021-2026) Table 44. Global Oral Contrast Agent Sales by Region (2021-2026) & (US$ Million) Table 45. Global Oral Contrast Agent Sales Market Share in Value by Region (2021-2026) Table 46. Global Oral Contrast Agent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Oral Contrast Agent Sales by Region (2027-2032) & (K Units) Table 48. Global Oral Contrast Agent Sales Market Share in Volume by Region (2027-2032) Table 49. Global Oral Contrast Agent Sales by Region (2027-2032) & (US$ Million) Table 50. Global Oral Contrast Agent Sales Market Share in Value by Region (2027-2032) Table 51. Global Oral Contrast Agent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Oral Contrast Agent Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Oral Contrast Agent Sales by Application (2021-2026) & (K Units) Table 54. Global Oral Contrast Agent Sales Market Share in Volume by Application (2021-2026) Table 55. Global Oral Contrast Agent Sales by Application (2021-2026) & (US$ Million) Table 56. Global Oral Contrast Agent Sales Market Share in Value by Application (2021-2026) Table 57. Global Oral Contrast Agent Price by Application (2021-2026) & (US$/Unit) Table 58. Global Oral Contrast Agent Sales by Application (2027-2032) & (K Units) Table 59. Global Oral Contrast Agent Sales Market Share in Volume by Application (2027-2032) Table 60. Global Oral Contrast Agent Sales by Application (2027-2032) & (US$ Million) Table 61. Global Oral Contrast Agent Sales Market Share in Value by Application (2027-2032) Table 62. Global Oral Contrast Agent Price by Application (2027-2032) & (US$/Unit) Table 63. North America Oral Contrast Agent Sales by Application (2021-2026) & (K Units) Table 64. North America Oral Contrast Agent Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Oral Contrast Agent Sales by Application (2021-2026) & (K Units) Table 66. Europe Oral Contrast Agent Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Oral Contrast Agent Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Oral Contrast Agent Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Oral Contrast Agent Sales by Application (2021-2026) & (K Units) Table 70. Latin America Oral Contrast Agent Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Oral Contrast Agent Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Oral Contrast Agent Sales by Application (2021-2026) & (US$ Million) Table 73. Daiichi Sankyo (Japan) Company Information Table 74. Daiichi Sankyo (Japan) Business Overview Table 75. Daiichi Sankyo (Japan) Oral Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Daiichi Sankyo (Japan) Oral Contrast Agent Product Portfolio Table 77. Daiichi Sankyo (Japan) Recent Development Table 78. Bayer HealthCare (Germany) Company Information Table 79. Bayer HealthCare (Germany) Business Overview Table 80. Bayer HealthCare (Germany) Oral Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Bayer HealthCare (Germany) Oral Contrast Agent Product Portfolio Table 82. Bayer HealthCare (Germany) Recent Development Table 83. Unijules Life Sciences (India) Company Information Table 84. Unijules Life Sciences (India) Business Overview Table 85. Unijules Life Sciences (India) Oral Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Unijules Life Sciences (India) Oral Contrast Agent Product Portfolio Table 87. Unijules Life Sciences (India) Recent Development Table 88. Taejoon Pharm (South Korea) Company Information Table 89. Taejoon Pharm (South Korea) Business Overview Table 90. Taejoon Pharm (South Korea) Oral Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Taejoon Pharm (South Korea) Oral Contrast Agent Product Portfolio Table 92. Taejoon Pharm (South Korea) Recent Development Table 93. Spago Nanomedicine (Sweden) Company Information Table 94. Spago Nanomedicine (Sweden) Business Overview Table 95. Spago Nanomedicine (Sweden) Oral Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Spago Nanomedicine (Sweden) Oral Contrast Agent Product Portfolio Table 97. Spago Nanomedicine (Sweden) Recent Development Table 98. Magnus Health (India) Company Information Table 99. Magnus Health (India) Business Overview Table 100. Magnus Health (India) Oral Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Magnus Health (India) Oral Contrast Agent Product Portfolio Table 102. Magnus Health (India) Recent Development Table 103. Lantheus (US) Company Information Table 104. Lantheus (US) Business Overview Table 105. Lantheus (US) Oral Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Lantheus (US) Oral Contrast Agent Product Portfolio Table 107. Lantheus (US) Recent Development Table 108. Jodas (India) Company Information Table 109. Jodas (India) Business Overview Table 110. Jodas (India) Oral Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Jodas (India) Oral Contrast Agent Product Portfolio Table 112. Jodas (India) Recent Development Table 113. J.B. Chemicals and Pharmaceuticals (India) Company Information Table 114. J.B. Chemicals and Pharmaceuticals (India) Business Overview Table 115. J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Product Portfolio Table 117. J.B. Chemicals and Pharmaceuticals (India) Recent Development Table 118. Guerbet (France) Company Information Table 119. Guerbet (France) Business Overview Table 120. Guerbet (France) Oral Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Guerbet (France) Oral Contrast Agent Product Portfolio Table 122. Guerbet (France) Recent Development Table 123. GE Healthcare (US) Company Information Table 124. GE Healthcare (US) Business Overview Table 125. GE Healthcare (US) Oral Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. GE Healthcare (US) Oral Contrast Agent Product Portfolio Table 127. GE Healthcare (US) Recent Development Table 128. Bracco Imaging (Italy) Company Information Table 129. Bracco Imaging (Italy) Business Overview Table 130. Bracco Imaging (Italy) Oral Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Bracco Imaging (Italy) Oral Contrast Agent Product Portfolio Table 132. Bracco Imaging (Italy) Recent Development Table 133. North America Oral Contrast Agent Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 134. North America Oral Contrast Agent Sales by Country (2021-2026) & (K Units) Table 135. North America Oral Contrast Agent Sales Market Share by Country (2021-2026) Table 136. North America Oral Contrast Agent Sales Forecast by Country (2027-2032) & (K Units) Table 137. North America Oral Contrast Agent Sales Market Share Forecast by Country (2027-2032) Table 138. North America Oral Contrast Agent Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. North America Oral Contrast Agent Market Size by Country (2021-2026) & (US$ Million) Table 140. North America Oral Contrast Agent Market Share by Country (2021-2026) Table 141. North America Oral Contrast Agent Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. North America Oral Contrast Agent Market Share Forecast by Country (2027-2032) Table 143. Europe Oral Contrast Agent Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 144. Europe Oral Contrast Agent Sales by Country (2021-2026) & (K Units) Table 145. Europe Oral Contrast Agent Sales Market Share by Country (2021-2026) Table 146. Europe Oral Contrast Agent Sales Forecast by Country (2027-2032) & (K Units) Table 147. Europe Oral Contrast Agent Sales Market Share Forecast by Country (2027-2032) Table 148. Europe Oral Contrast Agent Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Europe Oral Contrast Agent Market Size by Country (2021-2026) & (US$ Million) Table 150. Europe Oral Contrast Agent Market Share by Country (2021-2026) Table 151. Europe Oral Contrast Agent Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Europe Oral Contrast Agent Market Share Forecast by Country (2027-2032) Table 153. Asia-Pacific Oral Contrast Agent Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 154. Asia-Pacific Oral Contrast Agent Sales by Country (2021-2026) & (K Units) Table 155. Asia-Pacific Oral Contrast Agent Sales Market Share by Country (2021-2026) Table 156. Asia-Pacific Oral Contrast Agent Sales Forecast by Country (2027-2032) & (K Units) Table 157. Asia-Pacific Oral Contrast Agent Sales Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific Oral Contrast Agent Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific Oral Contrast Agent Market Size by Country (2021-2026) & (US$ Million) Table 160. Asia-Pacific Oral Contrast Agent Market Share by Country (2021-2026) Table 161. Asia-Pacific Oral Contrast Agent Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Asia-Pacific Oral Contrast Agent Market Share Forecast by Country (2027-2032) Table 163. Latin America Oral Contrast Agent Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 164. Latin America Oral Contrast Agent Sales by Country (2021-2026) & (K Units) Table 165. Latin America Oral Contrast Agent Sales Market Share by Country (2021-2026) Table 166. Latin America Oral Contrast Agent Sales Forecast by Country (2027-2032) & (K Units) Table 167. Latin America Oral Contrast Agent Sales Market Share Forecast by Country (2027-2032) Table 168. Latin America Oral Contrast Agent Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Latin America Oral Contrast Agent Market Size by Country (2021-2026) & (US$ Million) Table 170. Latin America Oral Contrast Agent Market Share by Country (2021-2026) Table 171. Latin America Oral Contrast Agent Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Latin America Oral Contrast Agent Market Share Forecast by Country (2027-2032) Table 173. Middle East and Africa Oral Contrast Agent Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 174. Middle East and Africa Oral Contrast Agent Sales by Country (2021-2026) & (K Units) Table 175. Middle East and Africa Oral Contrast Agent Sales Market Share by Country (2021-2026) Table 176. Middle East and Africa Oral Contrast Agent Sales Forecast by Country (2027-2032) & (K Units) Table 177. Middle East and Africa Oral Contrast Agent Sales Market Share Forecast by Country (2027-2032) Table 178. Middle East and Africa Oral Contrast Agent Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Middle East and Africa Oral Contrast Agent Market Size by Country (2021-2026) & (US$ Million) Table 180. Middle East and Africa Oral Contrast Agent Market Share by Country (2021-2026) Table 181. Middle East and Africa Oral Contrast Agent Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Middle East and Africa Oral Contrast Agent Market Share Forecast by Country (2027-2032) Table 183. Key Raw Materials Table 184. Raw Materials Key Suppliers Table 185. Oral Contrast Agent Distributors List Table 186. Oral Contrast Agent Customers List Table 187. Research Programs/Design for This Report Table 188. Authors List of This Report Table 189. Secondary Sources Table 190. Primary Sources List of Figures Figure 1. Oral Contrast Agent Image Figure 2. Global Oral Contrast Agent Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral Contrast Agent Market Size (2021-2032) & (US$ Million) Figure 4. Global Oral Contrast Agent Sales (2021-2032) & (K Units) Figure 5. Microbubble Contrast Media Image Figure 6. Global Microbubble Contrast Media Sales YoY Growth (2021-2032) & (K Units) Figure 7. Gadolinium-based Contrast Media Image Figure 8. Global Gadolinium-based Contrast Media Sales YoY Growth (2021-2032) & (K Units) Figure 9. Iodinated Contrast Media Image Figure 10. Global Iodinated Contrast Media Sales YoY Growth (2021-2032) & (K Units) Figure 11. Barium-based Contrast Media Image Figure 12. Global Barium-based Contrast Media Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Oral Contrast Agent Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Oral Contrast Agent Market Share by Type 2025 VS 2032 Figure 15. North America Oral Contrast Agent Sales Market Share in Volume by Type in 2025 Figure 16. North America Oral Contrast Agent Sales Market Share in Value by Type in 2025 Figure 17. Europe Oral Contrast Agent Sales Market Share in Volume by Type in 2025 Figure 18. Europe Oral Contrast Agent Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Oral Contrast Agent Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Oral Contrast Agent Sales Market Share in Value by Type in 2025 Figure 21. Latin America Oral Contrast Agent Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Oral Contrast Agent Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Oral Contrast Agent Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Oral Contrast Agent Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Oral Contrast Agent Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Cardiovascular Disorders Image Figure 28. Global Cardiovascular Disorders Sales YoY Growth (2021-2032) & (K Units) Figure 29. Gastrointestinal Disorders Image Figure 30. Global Gastrointestinal Disorders Sales YoY Growth (2021-2032) & (K Units) Figure 31. Nephrological Disorders Image Figure 32. Global Nephrological Disorders Sales YoY Growth (2021-2032) & (K Units) Figure 33. Neurological Disorders Image Figure 34. Global Neurological Disorders Sales YoY Growth (2021-2032) & (K Units) Figure 35. Musculoskeletal Disorders Image Figure 36. Global Musculoskeletal Disorders Sales YoY Growth (2021-2032) & (K Units) Figure 37. Cancer Image Figure 38. Global Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 39. Global Oral Contrast Agent Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Oral Contrast Agent Market Share by Application 2025 VS 2032 Figure 41. North America Oral Contrast Agent Sales Market Share in Volume by Application in 2025 Figure 42. North America Oral Contrast Agent Sales Market Share in Value by Application in 2025 Figure 43. Europe Oral Contrast Agent Sales Market Share in Volume by Application in 2025 Figure 44. Europe Oral Contrast Agent Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Oral Contrast Agent Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Oral Contrast Agent Sales Market Share in Value by Application in 2025 Figure 47. Latin America Oral Contrast Agent Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Oral Contrast Agent Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Oral Contrast Agent Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Oral Contrast Agent Sales Market Share in Value by Application in 2025 Figure 51. North America Oral Contrast Agent Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. North America Oral Contrast Agent Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Oral Contrast Agent Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Oral Contrast Agent Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Oral Contrast Agent Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Europe Oral Contrast Agent Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Oral Contrast Agent Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Oral Contrast Agent Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Oral Contrast Agent Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Asia-Pacific Oral Contrast Agent Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Oral Contrast Agent Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Oral Contrast Agent Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Oral Contrast Agent Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Latin America Oral Contrast Agent Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Oral Contrast Agent Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Oral Contrast Agent Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Oral Contrast Agent Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 68. Middle East and Africa Oral Contrast Agent Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Oral Contrast Agent Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Oral Contrast Agent Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Oral Contrast Agent Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Oral Contrast Agent Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Microbubble Contrast Media
  • Gadolinium-based Contrast Media
  • Iodinated Contrast Media
  • Barium-based Contrast Media
Applications
  • Cardiovascular Disorders
  • Gastrointestinal Disorders
  • Nephrological Disorders
  • Neurological Disorders
  • Musculoskeletal Disorders
  • Cancer
Companies covered
  • Daiichi Sankyo (Japan)
  • Bayer HealthCare (Germany)
  • Unijules Life Sciences (India)
  • Taejoon Pharm (South Korea)
  • Spago Nanomedicine (Sweden)
  • Magnus Health (India)
  • Lantheus (US)
  • Jodas (India)
  • J.B. Chemicals and Pharmaceuticals (India)
  • Guerbet (France)
  • GE Healthcare (US)
  • Bracco Imaging (Italy)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Oral Contrast Agent Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Oral Contrast Agent Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Oral Contrast Agent Market by Type
  6. 1.3.1 Microbubble Contrast Media
  7. 1.3.2 Gadolinium-based Contrast Media
  8. 1.3.3 Iodinated Contrast Media
  9. 1.3.4 Barium-based Contrast Media
  10. 1.4 Global Oral Contrast Agent Market Size by Type
  11. 1.4.1 Global Oral Contrast Agent Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Oral Contrast Agent Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Oral Contrast Agent Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Oral Contrast Agent Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Oral Contrast Agent Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Oral Contrast Agent Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Oral Contrast Agent Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Oral Contrast Agent Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Oral Contrast Agent Industry Trends
  2. 2.2 Oral Contrast Agent Industry Drivers
  3. 2.3 Oral Contrast Agent Industry Opportunities and Challenges
  4. 2.4 Oral Contrast Agent Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Oral Contrast Agent Revenue (2021-2026)
  2. 3.2 Global Top Players by Oral Contrast Agent Sales (2021-2026)
  3. 3.3 Global Top Players by Oral Contrast Agent Price (2021-2026)
  4. 3.4 Global Oral Contrast Agent Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Oral Contrast Agent Major Company Production Sites & Headquarters
  6. 3.6 Global Oral Contrast Agent Company, Product Type & Application
  7. 3.7 Global Oral Contrast Agent Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Oral Contrast Agent Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Oral Contrast Agent Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Oral Contrast Agent Tier 1, Tier 2, and Tier 3
4 Oral Contrast Agent Regional Status and Outlook
  1. 4.1 Global Oral Contrast Agent Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Oral Contrast Agent Historic Market Size by Region
  3. 4.2.1 Global Oral Contrast Agent Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Oral Contrast Agent Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Oral Contrast Agent Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Oral Contrast Agent Forecasted Market Size by Region
  7. 4.3.1 Global Oral Contrast Agent Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Oral Contrast Agent Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Oral Contrast Agent Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Oral Contrast Agent by Application
  1. 5.1 Oral Contrast Agent Market by Application
  2. 5.1.1 Cardiovascular Disorders
  3. 5.1.2 Gastrointestinal Disorders
  4. 5.1.3 Nephrological Disorders
  5. 5.1.4 Neurological Disorders
  6. 5.1.5 Musculoskeletal Disorders
  7. 5.1.6 Cancer
  8. 5.2 Global Oral Contrast Agent Market Size by Application
  9. 5.2.1 Global Oral Contrast Agent Market Size Overview by Application (2021-2032)
  10. 5.2.2 Global Oral Contrast Agent Historic Market Size Review by Application (2021-2026)
  11. 5.2.3 Global Oral Contrast Agent Forecasted Market Size by Application (2027-2032)
  12. 5.3 Key Regions Market Size by Application
  13. 5.3.1 North America Oral Contrast Agent Sales Breakdown by Application (2021-2026)
  14. 5.3.2 Europe Oral Contrast Agent Sales Breakdown by Application (2021-2026)
  15. 5.3.3 Asia-Pacific Oral Contrast Agent Sales Breakdown by Application (2021-2026)
  16. 5.3.4 South America Oral Contrast Agent Sales Breakdown by Application (2021-2026)
  17. 5.3.5 Middle East and Africa Oral Contrast Agent Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Daiichi Sankyo (Japan)
  2. 6.1.1 Daiichi Sankyo (Japan) Company Information
  3. 6.1.2 Daiichi Sankyo (Japan) Business Overview
  4. 6.1.3 Daiichi Sankyo (Japan) Oral Contrast Agent Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Daiichi Sankyo (Japan) Oral Contrast Agent Product Portfolio
  6. 6.1.5 Daiichi Sankyo (Japan) Recent Developments
  7. 6.2 Bayer HealthCare (Germany)
  8. 6.2.1 Bayer HealthCare (Germany) Company Information
  9. 6.2.2 Bayer HealthCare (Germany) Business Overview
  10. 6.2.3 Bayer HealthCare (Germany) Oral Contrast Agent Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Bayer HealthCare (Germany) Oral Contrast Agent Product Portfolio
  12. 6.2.5 Bayer HealthCare (Germany) Recent Developments
  13. 6.3 Unijules Life Sciences (India)
  14. 6.3.1 Unijules Life Sciences (India) Company Information
  15. 6.3.2 Unijules Life Sciences (India) Business Overview
  16. 6.3.3 Unijules Life Sciences (India) Oral Contrast Agent Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Unijules Life Sciences (India) Oral Contrast Agent Product Portfolio
  18. 6.3.5 Unijules Life Sciences (India) Recent Developments
  19. 6.4 Taejoon Pharm (South Korea)
  20. 6.4.1 Taejoon Pharm (South Korea) Company Information
  21. 6.4.2 Taejoon Pharm (South Korea) Business Overview
  22. 6.4.3 Taejoon Pharm (South Korea) Oral Contrast Agent Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Taejoon Pharm (South Korea) Oral Contrast Agent Product Portfolio
  24. 6.4.5 Taejoon Pharm (South Korea) Recent Developments
  25. 6.5 Spago Nanomedicine (Sweden)
  26. 6.5.1 Spago Nanomedicine (Sweden) Company Information
  27. 6.5.2 Spago Nanomedicine (Sweden) Business Overview
  28. 6.5.3 Spago Nanomedicine (Sweden) Oral Contrast Agent Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Spago Nanomedicine (Sweden) Oral Contrast Agent Product Portfolio
  30. 6.5.5 Spago Nanomedicine (Sweden) Recent Developments
  31. 6.6 Magnus Health (India)
  32. 6.6.1 Magnus Health (India) Company Information
  33. 6.6.2 Magnus Health (India) Business Overview
  34. 6.6.3 Magnus Health (India) Oral Contrast Agent Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Magnus Health (India) Oral Contrast Agent Product Portfolio
  36. 6.6.5 Magnus Health (India) Recent Developments
  37. 6.7 Lantheus (US)
  38. 6.7.1 Lantheus (US) Company Information
  39. 6.7.2 Lantheus (US) Business Overview
  40. 6.7.3 Lantheus (US) Oral Contrast Agent Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Lantheus (US) Oral Contrast Agent Product Portfolio
  42. 6.7.5 Lantheus (US) Recent Developments
  43. 6.8 Jodas (India)
  44. 6.8.1 Jodas (India) Company Information
  45. 6.8.2 Jodas (India) Business Overview
  46. 6.8.3 Jodas (India) Oral Contrast Agent Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Jodas (India) Oral Contrast Agent Product Portfolio
  48. 6.8.5 Jodas (India) Recent Developments
  49. 6.9 J.B. Chemicals and Pharmaceuticals (India)
  50. 6.9.1 J.B. Chemicals and Pharmaceuticals (India) Company Information
  51. 6.9.2 J.B. Chemicals and Pharmaceuticals (India) Business Overview
  52. 6.9.3 J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Product Portfolio
  54. 6.9.5 J.B. Chemicals and Pharmaceuticals (India) Recent Developments
  55. 6.10 Guerbet (France)
  56. 6.10.1 Guerbet (France) Company Information
  57. 6.10.2 Guerbet (France) Business Overview
  58. 6.10.3 Guerbet (France) Oral Contrast Agent Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Guerbet (France) Oral Contrast Agent Product Portfolio
  60. 6.10.5 Guerbet (France) Recent Developments
  61. 6.11 GE Healthcare (US)
  62. 6.11.1 GE Healthcare (US) Company Information
  63. 6.11.2 GE Healthcare (US) Business Overview
  64. 6.11.3 GE Healthcare (US) Oral Contrast Agent Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 GE Healthcare (US) Oral Contrast Agent Product Portfolio
  66. 6.11.5 GE Healthcare (US) Recent Developments
  67. 6.12 Bracco Imaging (Italy)
  68. 6.12.1 Bracco Imaging (Italy) Company Information
  69. 6.12.2 Bracco Imaging (Italy) Business Overview
  70. 6.12.3 Bracco Imaging (Italy) Oral Contrast Agent Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Bracco Imaging (Italy) Oral Contrast Agent Product Portfolio
  72. 6.12.5 Bracco Imaging (Italy) Recent Developments
7 North America by Country
  1. 7.1 North America Oral Contrast Agent Sales by Country
  2. 7.1.1 North America Oral Contrast Agent Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Oral Contrast Agent Sales by Country (2021-2026)
  4. 7.1.3 North America Oral Contrast Agent Sales Forecast by Country (2027-2032)
  5. 7.2 North America Oral Contrast Agent Market Size by Country
  6. 7.2.1 North America Oral Contrast Agent Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Oral Contrast Agent Market Size by Country (2021-2026)
  8. 7.2.3 North America Oral Contrast Agent Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Oral Contrast Agent Sales by Country
  2. 8.1.1 Europe Oral Contrast Agent Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Oral Contrast Agent Sales by Country (2021-2026)
  4. 8.1.3 Europe Oral Contrast Agent Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Oral Contrast Agent Market Size by Country
  6. 8.2.1 Europe Oral Contrast Agent Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Oral Contrast Agent Market Size by Country (2021-2026)
  8. 8.2.3 Europe Oral Contrast Agent Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Oral Contrast Agent Sales by Country
  2. 9.1.1 Asia-Pacific Oral Contrast Agent Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Oral Contrast Agent Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Oral Contrast Agent Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Oral Contrast Agent Market Size by Country
  6. 9.2.1 Asia-Pacific Oral Contrast Agent Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Oral Contrast Agent Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Oral Contrast Agent Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Oral Contrast Agent Sales by Country
  2. 10.1.1 South America Oral Contrast Agent Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Oral Contrast Agent Sales by Country (2021-2026)
  4. 10.1.3 South America Oral Contrast Agent Sales Forecast by Country (2027-2032)
  5. 10.2 South America Oral Contrast Agent Market Size by Country
  6. 10.2.1 South America Oral Contrast Agent Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Oral Contrast Agent Market Size by Country (2021-2026)
  8. 10.2.3 South America Oral Contrast Agent Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Oral Contrast Agent Sales by Country
  2. 11.1.1 Middle East and Africa Oral Contrast Agent Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Oral Contrast Agent Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Oral Contrast Agent Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Oral Contrast Agent Market Size by Country
  6. 11.2.1 Middle East and Africa Oral Contrast Agent Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Oral Contrast Agent Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Oral Contrast Agent Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Oral Contrast Agent Value Chain Analysis
  2. 12.1.1 Oral Contrast Agent Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Oral Contrast Agent Production Mode & Process
  7. 12.2 Oral Contrast Agent Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Oral Contrast Agent Distributors
  10. 12.2.3 Oral Contrast Agent Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst